Microfluidics Device Market Share

Microfluidic devises Market overview

According to the latest report, the Microfluidic Devices market size is predicted to reach USD 151.8 Billion by the end of the year 2022-2030 with a significant growth rate of CAGR of 21.8%. A Microfluidic device utilizes the chemical and physical properties of gases and liquids at a micro-scale. This device provides various benefits over evenly sized systems. Microfluidics investigates and uses fewer samples volume, chemicals, and also decreases global fees of applications.  

The microfluidic device is an advanced technology that helps integrate several medical tests on a single chip. It is an important technology for miniaturization, integration, industrialization, and parallelization of several tests in different fields of biological research, in developments of drugs, and diagnosis. The rise in demand for the microfluidic technologies for miniaturization of the chip and testing products are the major driving factors for the growth of the Microfluidic Devices market. The increasing demand for genomics and proteomics are some other major driving factors. Moreover, the rigid policies of the government may hamper the growth of the Microfluidic Devices market.

This report contains all the information on the Microfluidic Devices market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the Microfluidic Devices market and forecast to 2025 is also included in the report.

Covid 19 Analysis

The outbreak of the global pandemic covid 19 has affected the Microfluidic Devices market, by creating a burden on the laboratories due to the large numbers of cases that were supposed to be tested in the labs. Hence, there is some positive impact as well; Microfluidic is basically handling of a small number of fields in chambers and microscale channels. It helps the researchers to manage fewer amounts of samples and generates faster results as compared to the conventional methods, just because of the high potentials in advanced microfluidic technology. This technology is considered the promising technology in this global pandemic situation of covid 19.

Market DynamicDrivers

The advancement in the technology of diagnosis devices is the major factor propelling the growth of the Microfluidic Devices market. Along with that, the rising incidence of chronic diseases and accordingly increased demand for Microfluidic technology has further boosted the demand for the Microfluidic Devices market.Opportunities

The current scenario of the market is witnessing major advancement in technology, as the developments in Microfluidic are leading towards the cost-effective mass production process of diagnostic devices. it is also creating various opportunities for the major key manufacturers in the market as well by pairing smartphones to Microfluidic which enables the deployment of point-of-care testing. The application of Microfluidic devices is likely to boost the demand for the Microfluidic devices market in the future.Restraints

The lack of skilled technicians in the Microfluidic along with the issues related to the regulatory environment is the major restraint of the global Microfluidic market. The high cost of Microfluidics types of equipment is another major restraint especially in the developing countries as it is unaffordable due to the emerging low income of such countries.Challenges

The major challenges faced by the key manufacturers of Microfluidic devices are to provide results immediately outside the conventional laboratory environment which involves point-of-care device market (POCT) testing. It is strongly impacting the growth of the Microfluidic Devices market.

Cumulative Growth Analysis

The increasing advancement in technology is the major key driving factor for the Microfluidic device market. For instance, in the month of January 2019, L’Oreal has launched a prototype of a wearable sensor from the L’Oreal Technology Incubator at the show of Consumers Electronic in 2019 and also introduced a companion app. The first wearable microfluidic sensor was introduced by My Skin Track pH by La Roche-Posay and companion app which helps to easily measure the pH balance in skin and accordingly creates some customized product regimens for better care for the skin.

Value Chain Analysis

According to the latest report the Microfluidic devices market has been segmented onto the basis of industry, materials, application, and regions. On the basis of industry, the Microfluidic devices market has been segmented into pharmaceutical, medical devices, in-veto diagnostics, and others. The pharmaceutical segment is further segmented into chips for lab analytics, accurate dispensing devices, and micro-reactors for drug synthesis. The in-veto segments account for the maximum shares of 50.6% in the year 2018 due to the increasing demand for early diagnosis.

On the basis of materials, the Microfluidic devices market has been segmented into glass, polymer, silicon, and others. The polymer segments account for the maximum share in the Microfluidic devices market due to its fast fabrication process and cheaper costs as compared to the glass and silicon. On the basis of application the Microfluidic devices market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

Segmentation Overview

The market is segmented on the basis of the industry, materials, application, and regions. The Microfluidic devices market is expected to witness decent growth during the forecast period.

By Application

Based on the application, the market is segmented into pharmaceutical and life science research, clinical and veterinary diagnostics, point of care diagnostics, analytical devices, drug delivery, environmental and industrial, and others.

By End-users

Based on the propulsion types, the market is segmented into pharmaceutical, medical devices, in-veto diagnostics, and others.

Regional Analysis

According to the latest reports, the Microfluidic devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East, and Africa. America accounts for the maximum share in the Microfluidic devices market due to the rising geriatric population, increasing chronic diseases and lifestyle diseases, raising awareness in healthcare, and the developments in technologies for several applications and along with that the extensive insurance infrastructure facilities are driving the growth of the Microfluidic Devices market.

Europe is expected to stand second in the Microfluidic devices market due to advancements in technology and the support of the major levy players for the growth of the Microfluidic devices market. Asia Pacific is predicted to register the maximum CAGR during the forecast period due to the introduction of new advanced products in these regions. The Middle East & Africa holds the least Microfluidic devices market share due to the low development in the economy mainly in the African region.

Competitive landscape

There are prominent players who are currently dominating the global Microfluidic devices industry in terms of market share. The key players are focused on investing in product innovations with the help of advanced technology; the smaller or mid-sized companies are increasing their presence in the global market by introducing better technologies at affordable prices.

Major Key Players

•         Abbott Laboratories


•         F. HOFFMANN-LA ROCHE AG


•         Agilent Technologies, Inc.


•         Siemens
  


•         Fluidigm


•         BIO-RAD LABORATORIES, INC.


•         CEPHEID


•         RainDance Technologies, Inc.


•         Dolomite Microfluidics


•         Micronit Microtechnologies


•         Johnson & Johnson Services, Inc.


•         BD


•         Elveflow


•         Perkinelmer Inc.


•         Thermo Fisher Scientific Inc.


•         BioMérieux

Report Overview

The following report comprises of –

•         Market overview 


•         Covid 19 Analysis


•         Market Dynamic


•         Drivers


•         Opportunities


•         Restraints 


•         Challenges


•         Cumulative Growth Analysis


•         Value Chain Analysis


•         Segmentation Overview 


•         By Application 


•         By End-Users


•         Regional Analysis


•         Competitive landscape

Recent Developments

• 
  In March 2015, BD acquired CareFusion Corporation for USD12.2 billion. CareFusion operates as a wholly-owned subsidiary of BD. The acquisition is intended to enhance the medication management and patient safety solutions provided by BD. 

Market Segmentation

Microfluidic Devices Market, by Industry

• In-Vitro Diagnostics


• Pharmaceutical


• Chips for Lab Analytics


• Accurate Dispensing Devices


• Micro-reactors for Drug SynthesisMedical Devices
  

• Micro Pumps and Dispensing System


• Inhalers


• Micro-Needles


• Others

Microfluidic Devices Market, by Material

• Polymer


• Glass


• Silicon


• Others

Microfluidic Devices Market, by Application

• Pharmaceutical and Life Science Research


• Clinical and Veterinary Diagnostics


• Point of Care Diagnostics


• Analytical Devices


• Drug Delivery


• Environmental and Industrial


• Others

Microfluidic Devices Market, by Region

• Americas
  
  
  
  • North America
  
  
  
  


• US


• Canada

• 
  
  
  
  • Latin America
  
  
  
  


• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • UK
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa